Oncorus Inc. (ONCR) Social Stream



Oncorus Inc. (ONCR): $1.25

-0.04 (-3.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ONCR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 407

in industry

Oncorus Inc (ONCR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ONCR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 3 $40 $29 $34.666 $1.78 1847.53%
2021-11-15 3 $40 $19 $31.333 $1.78 1660.28%
2022-03-09 3 $40 $19 $26.333 $1.78 1379.38%
2022-03-28 3 $40 $7 $21.5 $1.78 1107.87%

The Trend in the Analyst Price Target


ONCR's average price target has moved down $17.17 over the prior 14 months.

ONCR reports an average of 313.43% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 1 45 31 37.750 16.36 130.75%
2021-07-10 1 45 31 37.750 13.43 181.09%
2021-07-17 1 45 31 37.750 13.34 182.98%
2021-08-14 1 45 29 37.250 10.70 248.13%
2022-03-09 2 40 19 26.333 2.00 1216.65%

ONCR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how Oncorus Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 497.91% of that group.
  • ONCR has a greater number of analysts covering the stock than 49.27% of all US stocks.
  • ONCR has a lower variance in analysts' estimates than -293.93% of stocks in the small market cap category.
  • In the context of stocks in the small market cap category, Oncorus Inc's average analyst price target is greater than 317.7% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Oncorus Inc are OMER, OLMA, and OGI.

What is the outlook for ONCR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5014 seconds.